您的位置: 首页 > 农业专利 > 详情页

IFN-ALPHA/BETA-INDEPENDENT MECHANISM OF ANTIVIRAL PROTECTION THROUGH A NOVEL LIGAND-RECEPTOR PAIR: IFN-LAMBDA LIGANDS ENGAGE A NOVEL RECEPTOR IFN-LAMBDA R1 (CRF2-12) AND IL-10R2 (CRF2-4) FOR SIGNALING AND INDUCTION OF BIOLOGICAL ACTIVITIES
专利权人:
Rutgers; The State University of New Jersey
发明人:
Sergei V. Kotenko,Grant F. Gallagher
申请号:
US15869503
公开号:
US20180243377A1
申请日:
2018.01.12
申请国别(地区):
US
年份:
2018
代理人:
摘要:
A novel IFN-α/ß independent ligand receptor system which upon engagement leads, among other things, to the establishment of an anti-viral state is disclosed. Further disclosed are three closely positioned genes on human chromosome 19 that encode distinct but highly homologous proteins, designated IFN-λ1, IFN-λ2, IFN-λ3, based inter alia, in their ability to induce antiviral protection. Expression of these proteins is induced upon viral infection. A receptor complex utilized by all three IFN-λ proteins for signaling is also disclosed. The receptor complex is generally composed of two subunits, a novel receptor designated IFN-λR1 or CRF2-12, and a second subunit, IL-10R2 or CRF2-4, which is also a shared receptor component for the IL-10 and IL-22 receptor complexes. The gene encoding IFN-λR1 is generally widely expressed, including many different cell types and tissues. Expression of these proteins is induced by immune events, including, for example, upon viral infection. Apoptotosis may also be induced under effective conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充